Stock listing
0HNC Stock Price, News, Filings & Events — Biomarin Pharmaceutical Inc.
Selected listing: 0HNC · LSE · USD · GB
This page tracks Biomarin Pharmaceutical Inc.'s 0HNC:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0HNC:LSE. 0HNC:LSE is the stock-level entry point for investors researching Biomarin Pharmaceutical Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 0HNC:LSE
- Asset type
- Stock
- Market cap
- $12.52B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- USD
Biomarin Pharmaceutical Inc. 0HNC:LSE stock context
This page tracks Biomarin Pharmaceutical Inc.'s 0HNC:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0HNC:LSE. 0HNC:LSE is the stock-level entry point for investors researching Biomarin Pharmaceutical Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Biomarin Pharmaceutical Inc.
BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical P...
August 18, 2026
BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston
August 10, 2026
BioMarin to Host Second Quarter 2026 Financial Results Conference Call and Webcast on Thursday, August 6, 2026, at 4:30pm ET
July 30, 2026
BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified Re...
July 27, 2026
U.S. Food and Drug Administration Accepts BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Chi...
July 13, 2026
Biomarin Pharmaceutical Inc. earnings calls
BioMarin Pharmaceutical Inc. (BMRN) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
BioMarin Pharmaceutical Inc. (BMRN) Q1 2026 Earnings Call
May 4, 2026 · Replay with transcript and chapters
BioMarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Call
February 23, 2026 · Replay with transcript and chapters
BioMarin Pharmaceutical Inc. (BMRN) Q3 2025 Earnings Call
October 27, 2025 · Replay with transcript and chapters
BioMarin Pharmaceutical Inc. (BMRN) Q2 2025 Earnings Call
August 4, 2025 · Replay with transcript and chapters
BioMarin Pharmaceutical Inc. (BMRN) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Biomarin Pharmaceutical Inc.
Biomarin Pharmaceutical Inc. investor report
Review AI stock analysis and investor report context for 0HNC:LSE.
Biomarin Pharmaceutical Inc. company profile
View the public company page for Biomarin Pharmaceutical Inc. on 6ix.
Biomarin Pharmaceutical Inc. news
Read company news and market updates connected to Biomarin Pharmaceutical Inc..
Biomarin Pharmaceutical Inc. investor events
Find investor webinars, events, and replay context for Biomarin Pharmaceutical Inc..
Alternate listings
BMRN:NASDAQ
US · USD
Alternate listing for Biomarin Pharmaceutical Inc.; the primary context on this page is 0HNC:LSE.
BM8:GETTEX
DE · EUR
Alternate listing for Biomarin Pharmaceutical Inc.; the primary context on this page is 0HNC:LSE.
BM8:TRADEGATE
DE · EUR
Alternate listing for Biomarin Pharmaceutical Inc.; the primary context on this page is 0HNC:LSE.
924801:LSX
DE · EUR
Alternate listing for Biomarin Pharmaceutical Inc.; the primary context on this page is 0HNC:LSE.
BM8:FWB
DE · EUR
Alternate listing for Biomarin Pharmaceutical Inc.; the primary context on this page is 0HNC:LSE.
BMRN:BMV
MX · MXN
Alternate listing for Biomarin Pharmaceutical Inc.; the primary context on this page is 0HNC:LSE.
924801:LS
DE · EUR
Alternate listing for Biomarin Pharmaceutical Inc.; the primary context on this page is 0HNC:LSE.
B1MR34:BMFBOVESPA
BR · BRL
Alternate listing for Biomarin Pharmaceutical Inc.; the primary context on this page is 0HNC:LSE.
1BMRN:MIL
IT · EUR
Alternate listing for Biomarin Pharmaceutical Inc.; the primary context on this page is 0HNC:LSE.
BM8:BX
CH · CHF
Alternate listing for Biomarin Pharmaceutical Inc.; the primary context on this page is 0HNC:LSE.
4BMRN:EUROTLX
IT · EUR
Alternate listing for Biomarin Pharmaceutical Inc.; the primary context on this page is 0HNC:LSE.
BM8:MUN
DE · EUR
Alternate listing for Biomarin Pharmaceutical Inc.; the primary context on this page is 0HNC:LSE.